Considering the abundance of HspB5 expression in peripheral tissues and its potential therapeutic value for counteracting inflammation and supporting neuroprotection, HspB5 is a promising candidate to test in the context of infection/inflammation-induced sensorineural hearing loss. Here, CRYAB is linked to infection.